论文信息 - Antibodies to neuronal surface proteins in Tourette Syndrome: Lack of evidence in a European paediatric cohort - 字舞流文

Antibodies to neuronal surface proteins in Tourette Syndrome: Lack of evidence in a European paediatric cohort

P. Paschou | V. Roessner | D. Martino | A. Schrag | M. Schwarz | I. Heyman | C. Huyser | P. Hoekstra | K. Müller-Vahl | A. Morer | I. Margarit | A. Münchau | F. Cardona | M. Buttiglione | P. Mir | A. Dietrich | B. Garcia-Delgar | Julie Hagstrøm | T. Hedderly | T. Openneer | E. Bartolini | G. Orefici | A. Hagen | A. Apter | N. Benaroya-Milshtein | G. Laviola | S. Macrì | Zacharias Anastasiou | A. Vincent | B. Bodmer | Marco Tallon | L. Jacobson | D. Menassa | M. P. Giannoccaro | E. Coutinho | A. Efstratiou | M. Gulisano | R. Rizzo | Z. Tarnok | V. Baglioni | R. Creti | P. Silvestri | P. Roazzi | N. Debes | L. Skov | Maria Gariup | T. Steinberg | P. Nagy | M. Imperi | I. Karagiannidis | D. Ruhrman | N. Moll | J. Schnell | B. Burger | E. Bognár | M. C. Vela | M. C. Ferro | Valeria Neri | Alessandra Pellico | C. Porcelli | Sara Stöber | Anna Marotta | M. Redondo | G. Schütze | M. Madruga‐Garrido | Marianthi Georgitsi | U. Meier | O. Petruzzelli | C. Fremer | A. Vincent | Noa Benaroya-Milshtein

[1] K. Müller-Vahl,et al. Immunity in Gilles de la Tourette-Syndrome: Results From a Cerebrospinal Fluid Study , 2019, Front. Neurol..

[2] P. Paschou,et al. European Multicentre Tics in Children Studies (EMTICS): protocol for two cohort studies to assess risk factors for tic onset and exacerbation in children and adolescents , 2018, European Child & Adolescent Psychiatry.

[3] A. Cavanna. Gilles de la Tourette syndrome as a paradigmatic neuropsychiatric disorder , 2018, CNS Spectrums.

[4] R. Albin. Tourette syndrome: a disorder of the social decision-making network , 2018, Brain : a journal of neurology.

[5] Paul J. Harrison,et al. CASPR2 autoantibodies are raised during pregnancy in mothers of children with mental retardation and disorders of psychological development but not autism , 2017, Journal of Neurology, Neurosurgery, and Psychiatry.

[6] C. Pittenger,et al. Microglial Dysregulation in OCD, Tourette Syndrome, and PANDAS , 2016, Journal of immunology research.

[7] B. Volpe,et al. Caspr2-reactive antibody cloned from a mother of an ASD child mediates an ASD-like phenotype in mice , 2016, Molecular Psychiatry.

[8] T. Shimada,et al. Prevalence of elevated serum anti-N-methyl-D-aspartate receptor antibody titers in patients presenting exclusively with psychiatric symptoms: a comparative follow-up study , 2016, BMC Psychiatry.

[9] K. Müller-Vahl,et al. Gilles de la Tourette syndrome is not linked to contactin-associated protein receptor 2 antibodies , 2015, Molecular Brain.

[10] D. Martino,et al. The role of immune mechanisms in Tourette syndrome , 2015, Brain Research.

[11] E. Kaplan,et al. Neuronal Antibody Biomarkers for Sydenham’s Chorea Identify a New Group of Children with Chronic Recurrent Episodic Acute Exacerbations of Tic and Obsessive Compulsive Symptoms Following a Streptococcal Infection , 2015, PloS one.

[12] M. Poot. Connecting the CNTNAP2 Networks with Neurodevelopmental Disorders , 2015, Molecular Syndromology.

[13] H. Singer,et al. Anti-streptococcal, tubulin, and dopamine receptor 2 antibodies in children with PANDAS and Tourette syndrome: Single-point and longitudinal assessments , 2013, Journal of Neuroimmunology.

[14] M. Edwards,et al. Environmental factors in Tourette syndrome , 2013, Neuroscience & Biobehavioral Reviews.

[15] M. Skalej,et al. Increased prevalence of diverse N-methyl-D-aspartate glutamate receptor antibodies in patients with an initial diagnosis of schizophrenia: specific relevance of IgG NR1a antibodies for distinction from N-methyl-D-aspartate glutamate receptor encephalitis. , 2013, JAMA psychiatry.

[16] M. Horne,et al. Antibodies to surface dopamine-2 receptor in autoimmune movement and psychiatric disorders. , 2012, Brain : a journal of neurology.

[17] C. Yeh,et al. Hyperpolarisation-activated cyclic nucleotide channel 4 (HCN4) involvement in Tourette's syndrome autoimmunity , 2012, Journal of Neuroimmunology.

[18] J. Dalmau,et al. Neuronal autoantigens—pathogenesis, associated disorders and antibody testing , 2012, Nature Reviews Neurology.

[19] D. Joel,et al. Behavioral, Pharmacological, and Immunological Abnormalities after Streptococcal Exposure: A Novel Rat Model of Sydenham Chorea and Related Neuropsychiatric Disorders , 2012, Neuropsychopharmacology.

[20] K. Müller-Vahl,et al. Oligoclonal bands in cerebrospinal fluid in patients with Tourette's syndrome , 2011, Movement disorders : official journal of the Movement Disorder Society.

[21] A. Vincent,et al. Antibodies to Kv1 potassium channel-complex proteins leucine-rich, glioma inactivated 1 protein and contactin-associated protein-2 in limbic encephalitis, Morvan’s syndrome and acquired neuromyotonia , 2010, Brain : a journal of neurology.

[22] Jun Liu,et al. Morphologic features of the amygdala and hippocampus in children and adults with Tourette syndrome. , 2007, Archives of general psychiatry.

[23] J. Leckman,et al. Decreased Numbers of Regulatory T Cells Suggest Impaired Immune Tolerance in Children with Tourette Syndrome: A Preliminary Study , 2007, Biological Psychiatry.

[24] S. Kaech,et al. Culturing hippocampal neurons , 2006, Nature Protocols.

[25] Haiqun Lin,et al. Increased serum levels of interleukin-12 and tumor necrosis factor-alpha in Tourette’s syndrome , 2005, Biological Psychiatry.

[26] P. Heutink,et al. CNTNAP2 is disrupted in a family with Gilles de la Tourette syndrome and obsessive compulsive disorder. , 2003, Genomics.

[27] J. Leckman,et al. Tourette's syndrome , 2002, The Lancet.

[28] A. Vincent,et al. Detection of NMDARs Antibodies in Encephalitis. , 2017, Methods in molecular biology.

[29] A. Vincent,et al. Voltage-gated potassium channel-complex autoimmunity and associated clinical syndromes. , 2016, Handbook of clinical neurology.